Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Outlook Therapeutics Inc (NQ: OTLK )

5.140 +0.010 (+0.19%)
Streaming Delayed Price Updated: 12:05 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 116,044
Open 5.140
Bid (Size) 5.120 (2)
Ask (Size) 5.140 (3)
Prev. Close 5.130
Today's Range 4.990 - 5.220
52wk Range 4.610 - 12.85
Shares Outstanding 23,655,636
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OUTLOOK ALERT: Bragar Eagel & Squire, P.C. is Investigating Outlook Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga

Performance

YTD
-34.62%
-34.62%
1 Month
-7.22%
-7.22%
3 Month
-28.31%
-28.31%
6 Month
-31.74%
-31.74%
1 Year
-42.96%
-42.96%

More News

Read More
OTLK Stock Earnings: Outlook Therapeutics Beats EPS for Q3 2024
Via InvestorPlace
3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices
Via MarketBeat
3 Undervalued Gems Set to Soar 1,000% by 2026
Via InvestorPlace
MarketBeat Week in Review – 6/17 - 6/21
Via MarketBeat
Topics Economy Stocks
Exposures Interest Rates US Equities
Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
Via MarketBeat
OTLK Stock Earnings: Outlook Therapeutics Misses EPS for Q2 2024
Via InvestorPlace
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
Via InvestorPlace
Insiders Buying Outlook Therapeutics And 2 Other Stocks
Via Benzinga
Gold Moves Lower; Lululemon Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Dow Dips 200 Points; Nike Shares Fall After Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Higher On Friday?
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Topics Stocks
Exposures US Equities
7 of the Best Speculative Stocks You Can Snag for Less Than $1
Via InvestorPlace
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
OTLK DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
OTLK DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action – OTLK
From The Rosen Law Firm, P.A.
Via Business Wire
OTLK IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.